Mortality risk in current and new antipsychotic Alzheimer's disease users: Large scale Japanese study

Author:

Arai Heii1,Nakamura Yu2,Taguchi Masamoto3,Kobayashi Hiroyuki45,Yamauchi Keita6,Schneider Lon S.7,

Affiliation:

1. Department of Psychiatry and Behavioral Science, Graduate School of Medicine Juntendo University Tokyo Japan

2. Department of Psychiatry, Faculty of Medicine Kagawa University Kagawa Japan

3. Ohgaki Hospital Gifu Japan

4. School of Medicine Toho University Tokyo Japan

5. Otsuka Pharmaceutical Co., Ltd. Tokyo Japan

6. Graduate School of Health Management Keio University Kanagawa Japan

7. Keck School of Medicine University of Southern California Los Angeles USA

Funder

Otsuka Pharmaceutical

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Reference26 articles.

1. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition;Rabins PV;Am J Psychiatry,2007

2. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine

3. Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial

4. Antidepressants for agitation and psychosis in dementia;Seitz DP;Cochrane Database Syst Rev,2011

5. Donepezil for the Treatment of Agitation in Alzheimer's Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3